Journal Home
Search for

Volume 47, Issue 1, Pages 93-96 (January 2010)


View previous. 23 of 28 View next.

Novel hepatitis B virus subgenotype A6 in African-Belgian patients

Mahmoud Reza Pourkarimab, Philippe Lemeyc, Samad Amini-Bavil-Olyaeed, Piet Maesa, Marc Van RanstaCorresponding Author Informationemail address

Received 21 September 2009; accepted 25 September 2009. published online 26 October 2009.

Abstract 

Background

Genome diversity of hepatitis B virus (HBV) is prominent among DNA viruses; which, allowed the virus to be genetically classified into eight genotypes and several subgenotypes.

Objective

To introduce and to characterize a novel subgenotype HBV, classified as A6.

Study design

HBV full-length genomes were isolated and sequenced from three African-Belgian patients chronically infected with the virus. Using phylogenetic reconstruction and genetic distance calculation, the evolutionary relationships of the novel strains were investigated.

Results

Phylogenetic analysis based on complete genome sequences of genotype A strains revealed distinct clusters supported by high bootstrap values. The three African-Belgian strains clustered separately from the other known A subgenotypes (A1–A5) with maximal bootstrap support (100%). The mean inter-subgenotypic nucleotide divergence over the complete genome sequence between the novel A6 strains and A1–A5 was higher than 4%.

Conclusion

Phylogenetic analysis of the complete genome sequences yielded maximal bootstrap value support for nodes that establish the new lineage as a novel subgenotype. In addition, nucleotide divergence more than 4% based on full-length genome of the virus, clearly demonstrated that the three African-Belgian strains belonged to a novel subgenotype of HBV, which was assigned as “A6”. Noteworthy, the phylogeny of genotype A demonstrated that the A6 is a basal lineage that diverged earlier from the other African subgenotypes of genotype A.

a Laboratory of Clinical Virology, Rega Institute for Medical Research, University of Leuven, Minderbroedersstraat 10, BE-3000 Leuven, Belgium

b Research Center, Iranian Blood Transfusion Organization, (IBTO), Tehran, Iran

c Laboratory of Evolutionary Virology, Rega Institute for Medical Research, Leuven, Belgium

d Biotechnology Department, Pasteur Institute of Iran, 13164 Tehran, Iran

Corresponding Author InformationCorresponding author at: Tel.: +32 16 347908; fax: +32 16 332131.

PII: S1386-6532(09)00480-6

doi:10.1016/j.jcv.2009.09.032


View previous. 23 of 28 View next.